2-(3-溴-4-氯苯基)乙腈 | 249647-28-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(3-溴-4-氯苯基)乙腈
• 英文名称: 3-bromo-4-chlorobenzyl cyanide
• 英文别名: (3-bromo-4-chlorophenyl)-acetonitrile；2-(3-Bromo-4-chlorophenyl)acetonitrile
• CAS: 249647-28-7
• 化学式: C₈H₅BrClN
• 分子量: 230.491
• InChiKey: MHPCTXBOVJTCKT-UHFFFAOYSA-N

物化性质

• 沸点：
  324.0±27.0 °C(Predicted)
• 密度：
  1.603±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  2-(3-溴-4-氯苯基)乙腈 在 吡啶 、 sodium hydroxide 、 盐酸羟胺 作用下， 以 乙二醇二甲醚 、 乙醇 为溶剂， 反应 63.5h， 生成
  参考文献：
  名称：

  Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

  摘要：

  A series of 1,2,4-oxadiazole analogues has been shown to be potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70, a potential therapeutic target for immune suppression. These compounds typically are 200-400-fold more potent than the native, monophosphorylated tetrapeptide sequences. When compared with the high-affinity xi-1-ITAM peptide (Ac-NQL-pYNELNLGRREE-pYDVLD-NH2, wherein pY refers to phosphotyrosine) some of the best 1,2,4-oxadiazole analogues are approximately 1 order of magnitude less active. This series of compounds displays an unprecedented level of selectivity over the closely related tyrosine kinase Syk, as well as other SH2-containing proteins such as Src and Grb2. Gel shift studies using a protein construct consisting only of C-terminal ZAP-70 SH2 demonstrate that these compounds can effectively engage this particular SH2 domain.

  DOI：

  10.1021/jm990229t
• 作为产物：
  描述：

  对氯苯甲酸甲酯 在 N-溴代丁二酰亚胺(NBS) 、 lithium aluminium tetrahydride 、 硫酸 、 三乙胺 、 sodium iodide 作用下， 以 乙醚 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 丁酮 为溶剂， 反应 34.5h， 生成 2-(3-溴-4-氯苯基)乙腈
  参考文献：
  名称：

  Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

  摘要：

  A series of 1,2,4-oxadiazole analogues has been shown to be potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70, a potential therapeutic target for immune suppression. These compounds typically are 200-400-fold more potent than the native, monophosphorylated tetrapeptide sequences. When compared with the high-affinity xi-1-ITAM peptide (Ac-NQL-pYNELNLGRREE-pYDVLD-NH2, wherein pY refers to phosphotyrosine) some of the best 1,2,4-oxadiazole analogues are approximately 1 order of magnitude less active. This series of compounds displays an unprecedented level of selectivity over the closely related tyrosine kinase Syk, as well as other SH2-containing proteins such as Src and Grb2. Gel shift studies using a protein construct consisting only of C-terminal ZAP-70 SH2 demonstrate that these compounds can effectively engage this particular SH2 domain.

  DOI：

  10.1021/jm990229t

文献信息

• [EN] AMINO ALCOHOL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS D'AMINO-ALCOOL ET LEURS UTILISATIONS
  申请人：YUMANITY THERAPEUTICS INC

  公开号：WO2021247910A1

  公开（公告）日：2021-12-09

  The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

  本发明涉及在治疗神经系统疾病中有用的化合物。本发明的化合物，单独或与其他药用活性剂结合，可用于治疗或预防神经系统疾病。
• PYRIMIDINYL PYRAZOLES AS INSECTICIDES AND PARASITICIDE ACTIVE AGENTS
  申请人：Frackenpohl Jens

  公开号：US20100144672A1

  公开（公告）日：2010-06-10

  The present invention relates to pyrimidinylpyrazoles and their use as insecticides, and also to processes for their preparation and to compositions comprising such arylpyrazoles.

  本发明涉及嘧啶基吡唑并将其用作杀虫剂，还涉及其制备过程以及包含这类芳基吡唑的组合物。
• Heteroaryl and benzyl amide compounds
  申请人：Conte Aurelia

  公开号：US20070185058A1

  公开（公告）日：2007-08-09

  Compounds of formula I wherein R 1 , R 2 , R 4 , R 5 , A, B, D and n are as defined, and pharmaceutically acceptable salts thereof, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them.

  式I中的化合物，其中R1、R2、R4、R5、A、B、D和n的定义如上，并其药用盐，其制备方法，它们作为药物的用途以及包含它们的药物组合物。
• Pyrimidinylpyrazole als insektizide und parasitizide Wirkstoffe
  申请人：Bayer CropScience AG

  公开号：EP2275422A1

  公开（公告）日：2011-01-19

  Die vorliegende Erfindung betrifft Pyrimidinylpyrazole der Formel (I) und ihre Verwendung als Insektizide sowie Verfahren zu ihrer Herstellung und Mittel, die solche Arylpyrazole enthalten.

  本发明涉及式（I）的嘧啶基吡唑及其作为杀虫剂的用途，以及其制备工艺和含有此类芳基吡唑的制剂。
• Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase
  作者：Sharada Labadie、Peter S. Dragovich、Jinhua Chen、Benjamin P. Fauber、Jason Boggs、Laura B. Corson、Charles Z. Ding、Charles Eigenbrot、HongXiu Ge、Qunh Ho、Kwong Wah Lai、Shuguang Ma、Shiva Malek、David Peterson、Hans E. Purkey、Kirk Robarge、Laurent Salphati、Steven Sideris、Mark Ultsch、Erica VanderPorten、BinQing Wei、Qing Xu、Ivana Yen、Qin Yue、Huihui Zhang、Xuying Zhang、Aihe Zhou

  DOI：10.1016/j.bmcl.2014.11.008

  日期：2015.1

  Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enone using structure-based design strategies resulted in inhibitors with considerable improvement in biochemical potency against human lactate dehydrogenase A (LDHA). These potent inhibitors were typically selective for LDHA over LDHB isoform (4-10 fold) and other structurally related malate dehydrogenases, MDH1 and MDH2 (>500 fold). An X-ray crystal structure of enzymatically most potent molecule bound to LDHA revealed two additional interactions associated with enhanced biochemical potency. (C) 2014 Elsevier Ltd. All rights reserved.